NCT01279057View on ClinicalTrials.gov

A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

727

Participants

Timeline

Start Date

December 27, 2010

Primary Completion Date

February 8, 2011

Study Completion Date

February 8, 2011

Conditions
Rhinitis, Allergic, Seasonal
Interventions
DRUG

Fluticasone furoate 27.5 mcg/actuation nasal spray (Lek Pharmaceuticals)

Nasal spray administered once daily at a dose of 110 mcg (4 actuations) for 14 days.

DRUG

Fluticasone furoate (Veramyst®) 27.5 mcg/actuation nasal spray

Nasal spray administered once daily at a dose of 110 mcg (4 actuations) for 14 days.

DRUG

Placebo

Placebo nasal spray administered once daily (4 actuations) for 14 days.

Trial Locations (7)

76712

Sandoz Investigational Site, Waco

78028

Sandoz Investigational Site, Kerrville

78130

Sandoz Investigational Site, New Braunfels

78229

Sandoz Investigational Site, San Antonio

78731

Sandoz Investigational Site, Austin

78750

Sandoz Investigational Site, Austin

78759

Sandoz Investigational Site, Austin

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY